Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and we’ll share relevant market report titles for you to explore.
- Product Profiles - Top 20 Cancer Therapy Brands
Report SummaryThe high level of commercial success experienced by the key companies in the oncology market makes it extremely attractive to drug developers. However, the shift toward a more personalized approach means...
- Market and Product Forecasts: Top 20 Oncology Therapy Brands - The value of the top 20 decreases as the oncology market fragments
IntroductionThe high level of commercial success experienced by the key companies in the oncology market makes it extremely attractive to drug developers. However, the shift toward a more personalized approach means fe...
- Market and Product Forecasts: Targeted Cancer Therapies - Trend towards personalized medicine will lead to market fragmentation
IntroductionThe targeted therapies class boasts several of the top-selling anticancer brands, and has fueled most of the recent rapid growth of the oncology market as a whole. In the next decade, several blockbuster ta...
- Commercial Insight: Top 20 Cancer Therapy Brands
The top 20 cancer therapies achieved sales of over $30 billion in 2009 accounting for 75% of all cancer therapy sales. The commercial success experienced by the key companies in the cancer the...
- Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019
IntroductionThe oncology market has witnessed a sizeable shift of focus away from cytotoxic therapies and antihormonal therapies towards the more lucrative targeted therapies and immunotherapies class in the last decade. Th...
- Commercial Insight: Antihormonal Cancer Therapies - Leading brands strive to minimize generic sales erosion
IntroductionAntihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential ...
- Top 20 Cancer Therapy Brands in Australia Forecast
IntroductionThe Top 20 cancer therapy brands in Australia reached sales of about $545m in 2008, growing at a CAGR of 30% since 2005. Datamonitor forecasts this growth to slow down considerably to a CAGR of 5.6% between 2008...
- Cancer Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report
Life Science Analytics', Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report contains detailed information on the colorectal cancer or colon cancer drug pipeline. This report provides insight in...
- Top 20 Cancer Therapy Brands Forecast
IntroductionThe cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion ...
- Forecast Insight: Top 20 Cancer Therapy Brands Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff
IntroductionThe cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven...